Abstract
Objective Develop a deep learning-based methodology using the foundations of systems pathology to generate highly accurate predictive tools for complex gastrointestinal diseases, using celiac disease (CD) as a prototype.
Design To predict the severity of CD, defined by Marsh–Oberhüber classification, we used deep learning to develop a model based on histopathologic features.
Results The study was based on a pediatric cohort of 124 patients identified with different classes of CD severity. The model predicted CD with an overall 88.7% accuracy with the highest for Marsh IIIc (91.0%; 95% sensitivity; 91% specificity). The model identified EECs as a defining feature of children with Marsh IIIc CD and endocrinopathies which was confirmed using immunohistochemistry.
Conclusion This deep learning image analysis platform has broad applications in disease treatment, management, and prognostication and paves the way for precision medicine.
What is already known about this subject?
– Deep Learning has the potential to generate predictive models for complex gastrointestinal diseases.
What are the new findings?
– Our deep learning-based model used the foundations of systems pathology to generate a highly accurate predictive tool for complex gastrointestinal diseases, using a celiac disease (CD) pediatric cohort as a prototype.
– The model predicated CD severity with high accuracy and identified enteroendocrine cells as a defining feature of children with severe CD and endocrinopathies.
How might it impact on clinical practice in the foreseeable future?
– Assessment of histopathological markers at the time of diagnosis that can predict risk of severity or complications can have broad applications in disease treatment, management, and prognostication and pave the way for precision medicine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this manuscript was supported by National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number K23DK117061-01A1 (Syed), University of Virginia Center for Engineering in Medicine Grant (Syed and Brown), and University of Virginia THRIV Scholar Career Development Award (Syed). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the UVA Institutional Review Board (IRB #20448).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest: The authors have declared that no conflict of interest exists.
Funding Information: Research reported in this manuscript was supported by National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number K23DK117061-01A1 (Syed), University of Virginia Center for Engineering in Medicine Grant (Syed and Brown), and University of Virginia THRIV Scholar Career Development Award (Syed). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
Data Availability
Data can be available on request
